David Ascher
David Ascher
Baker Institute; University of Melbourne; University of Cambridge
Verified email at unimelb.edu.au - Homepage
TitleCited byYear
mCSM: predicting the effects of mutations in proteins using graph-based signatures
DEV Pires, DB Ascher, TL Blundell
Bioinformatics 30 (3), 335-342, 2013
2342013
DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach
DEV Pires, DB Ascher, TL Blundell
Nucleic acids research 42 (W1), W314-W319, 2014
2142014
pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures
DEV Pires, TL Blundell, DB Ascher
Journal of medicinal chemistry 58 (9), 4066-4072, 2015
1762015
Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase
AL Albiston, CJ Morton, HL Ng, V Pham, HR Yeatman, S Ye, ...
The FASEB Journal 22 (12), 4209-4217, 2008
832008
Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
DB Ascher, J Wielens, TL Nero, L Doughty, CJ Morton, MW Parker
Scientific reports 4, 4765, 2014
762014
Arpeggio: a web server for calculating and visualising interatomic interactions in protein structures
HC Jubb, AP Higueruelo, B Ochoa-Montaņo, WR Pitt, DB Ascher, ...
Journal of molecular biology 429 (3), 365-371, 2017
602017
Flexibility and small pockets at protein–protein interfaces: new insights into druggability
H Jubb, TL Blundell, DB Ascher
Progress in biophysics and molecular biology 119 (1), 2-9, 2015
602015
Studies of Glutathione Transferase P1‐1 Bound to a Platinum (IV)‐Based Anticancer Compound Reveal the Molecular Basis of Its Activation
LJ Parker, LC Italiano, CJ Morton, NC Hancock, DB Ascher, JB Aitken, ...
Chemistry-A European Journal 17 (28), 7806-7816, 2011
602011
Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase
SY Chai, HR Yeatman, MW Parker, DB Ascher, PE Thompson, HT Mulvey, ...
BMC neuroscience 9 (2), S14, 2008
592008
DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair
BL Sibanda, DY Chirgadze, DB Ascher, TL Blundell
Science 355 (6324), 520-524, 2017
562017
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
J Phelan, F Coll, R McNerney, DB Ascher, DEV Pires, N Furnham, ...
BMC medicine 14 (1), 31, 2016
532016
SDM: a server for predicting effects of mutations on protein stability
AP Pandurangan, B Ochoa-Montaņo, DB Ascher, TL Blundell
Nucleic acids research 45 (W1), W229-W235, 2017
472017
In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity
DEV Pires, J Chen, TL Blundell, DB Ascher
Scientific Reports 6, 19848, 2016
452016
Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma
M Jafri, NC Wake, DB Ascher, DEV Pires, D Gentle, MR Morris, ...
Cancer discovery 5 (7), 723-729, 2015
452015
Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?
AD Watt, GAN Crespi, RA Down, DB Ascher, A Gunn, KA Perez, ...
Acta neuropathologica 127 (6), 803-810, 2014
452014
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer …
LM Kaminskas, DB Ascher, VM McLeod, MJ Herold, CP Le, EK Sloan, ...
Journal of controlled release 168 (2), 200-208, 2013
452013
Platinum: a database of experimentally measured effects of mutations on structurally defined protein–ligand complexes
DEV Pires, TL Blundell, DB Ascher
Nucleic acids research 43 (D1), D387-D391, 2014
422014
Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration
SC Feil, DB Ascher, MJ Kuiper, RK Tweten, MW Parker
Journal of molecular biology 426 (4), 785-792, 2014
412014
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on ‘black bone disease’ in Italy
M Nemethova, J Radvanszky, L Kadasi, DB Ascher, DEV Pires, ...
European Journal of Human Genetics 24 (1), 66, 2016
392016
mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance
DEV Pires, TL Blundell, DB Ascher
Scientific reports 6, 29575, 2016
352016
The system can't perform the operation now. Try again later.
Articles 1–20